PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni Suef, 62511, Egypt.\', \'Materials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni Suef, 62511, Egypt.\', \'Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky and the Lexington VA Medical Center, Lexington, KY, USA. abdel-latif@uky.edu.\', \'College of Medicine, University of Kentucky, Lexington, KY, 40506-0046, USA. abdel-latif@uky.edu.\', \'Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni Suef, 62511, Egypt. ahmed.lotfy@psas.bsu.edu.eg.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13287-021-02542-z
?:doi
?:hasPublicationType
?:journal
  • Stem cell research & therapy
is ?:pmid of
?:pmid
?:pmid
  • 34419143
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all